Literature DB >> 33434110

High-Performance Automated Anterior Circulation CT Angiographic Clot Detection in Acute Stroke: A Multireader Comparison.

Seena Dehkharghani1, Maarten Lansberg1, Chitra Venkatsubramanian1, Carlo Cereda1, Fabricio Lima1, Henrique Coelho1, Felipe Rocha1, Abid Qureshi1, Hafez Haerian1, Francisco Mont'Alverne1, Karen Copeland1, Jeremy Heit1.   

Abstract

Background Identification of large vessel occlusion (LVO) is critical to the management of acute ischemic stroke and prerequisite to endovascular therapy in recent trials. Increasing volumes and data complexity compel the development of fast, reliable, and automated tools for LVO detection to facilitate acute imaging triage. Purpose To investigate the performance of an anterior circulation LVO detection platform in a large mixed sample of individuals with and without LVO at cerebrovascular CT angiography (CTA). Materials and Methods In this retrospective analysis, CTA data from recent cerebrovascular trials (CRISP [ClinicalTrials.gov NCT01622517] and DASH) were enriched with local repositories from 11 worldwide sites to balance demographic and technical variables in LVO-positive and LVO-negative examinations. CTA findings were reviewed independently by two neuroradiologists from different institutions for intracranial internal carotid artery (ICA) or middle cerebral artery (MCA) M1 LVO; these observers were blinded to all clinical variables and outcomes. An automated analysis platform was developed and tested for prediction of LVO presence and location relative to reader consensus. Discordance between readers with respect to LVO presence or location was adjudicated by a blinded tertiary reader at a third institution. Sensitivity, specificity, and receiver operating characteristics were assessed by an independent statistician, and subgroup analyses were conducted. Prespecified performance thresholds were set at a lower bound of the 95% CI of sensitivity and specificity of 0.8 or greater at mean times to notification of less than 3.5 minutes. Results A total of 217 study participants (mean age, 64 years ± 16 [standard deviation]; 116 men; 109 with positive findings of LVO) were evaluated. Prespecified performance thresholds were exceeded (sensitivity, 105 of 109 [96%; 95% CI: 91, 99]; specificity, 106 of 108 [98%; 95% CI: 94, 100]). Sensitivity and specificity estimates across age, sex, location, and vendor subgroups exceeded 90%. The area under the receiver operating characteristic curve was 99% (95% CI: 97, 100). Mean processing and notification time was 3 minutes 18 seconds. Conclusion The results confirm the feasibility of fast automated high-performance detection of intracranial internal carotid artery and middle cerebral artery M1 occlusions. © RSNA, 2021 See also the editorial by Kloska in this issue.

Entities:  

Year:  2021        PMID: 33434110     DOI: 10.1148/radiol.2021202734

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  3 in total

1.  Diagnostic value of artificial intelligence automatic detection systems for breast BI-RADS 4 nodules.

Authors:  Shu-Yi Lyu; Yan Zhang; Mei-Wu Zhang; Bai-Song Zhang; Li-Bo Gao; Lang-Tao Bai; Jue Wang
Journal:  World J Clin Cases       Date:  2022-01-14       Impact factor: 1.337

2.  Diagnostic performance of an algorithm for automated large vessel occlusion detection on CT angiography.

Authors:  Sven P R Luijten; Lennard Wolff; Martijne H C Duvekot; Pieter-Jan van Doormaal; Walid Moudrous; Henk Kerkhoff; Geert J Lycklama A Nijeholt; Reinoud P H Bokkers; Lonneke S F Yo; Jeannette Hofmeijer; Wim H van Zwam; Adriaan C G M van Es; Diederik W J Dippel; Bob Roozenbeek; Aad van der Lugt
Journal:  J Neurointerv Surg       Date:  2021-08-19       Impact factor: 8.572

3.  Highly time-resolved 4D MR angiography using golden-angle radial sparse parallel (GRASP) MRI.

Authors:  Adam E Goldman-Yassen; Eytan Raz; Maria J Borja; Duan Chen; Anna Derman; Siddhant Dogra; Kai Tobias Block; Seena Dehkharghani
Journal:  Sci Rep       Date:  2022-09-05       Impact factor: 4.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.